Today: 3 May 2026

Vodafone Idea share price jumps today after ₹5,836 crore Vodafone Group deal and AGR moratorium headlines

Vodafone Idea share price jumps today after ₹5,836 crore Vodafone Group deal and AGR moratorium headlines

Vodafone Idea shares jumped 6% in Mumbai after the company announced a revised settlement with Vodafone Group promoters, unlocking ₹5,836 crore via cash and shares. Vodafone Group said it would settle the liability with €219 million in cash and 3.28 billion shares. India has granted Vodafone Idea a partial moratorium on $9.76 billion in AGR dues, deferring repayments by a decade, according to a government source.
1 January 2026
··
Sidus Space stock jumps 17% after $16.2 million share sale as market stays shut for New Year’s Day

Sidus Space stock jumps 17% after $16.2 million share sale as market stays shut for New Year’s Day

Sidus Space shares closed up 17% at $3.14 after completing a $16.2 million stock offering, with trading volume near 170 million shares. The stock ranged from $2.48 to $4.20 during the session. CVI Investments and Heights Capital Management disclosed a 7.4% stake in a new filing. Sidus agreed to issue placement agent warrants for up to 540,000 shares at $1.875 each.
1 January 2026
·
Edinburgh Hogmanay power cuts: Grassmarket pubs warn blackouts could hit New Year rush

Edinburgh Hogmanay power cuts: Grassmarket pubs warn blackouts could hit New Year rush

Repeated power outages hit Edinburgh’s Grassmarket on Dec. 30 and 31, disrupting festive trade as venues prepared for Hogmanay, operators said. SP Energy Networks blamed an intermittent fault and said extra staff were on standby. Businesses reported lost bookings and wasted stock, with some venues losing entire peak services. Operators urged the council and network to publish plans for upgrades and contingency measures.
1 January 2026
·
Visa stock today: $500 million escrow move reshapes share conversion math as markets shut

Visa stock today: $500 million escrow move reshapes share conversion math as markets shut

Visa lowered conversion rates for its class B-1 and B-2 shares after a $500 million litigation escrow deposit, according to a regulatory filing. The changes, effective Dec. 23, reduce the number of class A shares issued if conversion occurs. Visa shares closed down 0.8% at $350.71 ahead of the New Year holiday. The company has not set a date for its next earnings report.
1 January 2026
·
Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

Corcept Therapeutics shares fell 50.4% to $34.80 after the FDA declined to approve relacorilant for Cushing’s-related hypertension, citing a need for more evidence of effectiveness. The company plans to meet with the agency to discuss next steps. Wolfe Research downgraded the stock and removed projected sales for the indication. Trading volume reached about 20.16 million shares.
1 January 2026
··
Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

Axsome Therapeutics shares surged 22.9% to $182.64 after the FDA granted priority review to its application for AXS-05 in treating agitation in Alzheimer’s disease, setting an April 30 decision date. The company also plans to file for approval of AXS-12 for cataplexy in narcolepsy this month, following supportive FDA meeting minutes. Trading volume reached 3.1 million shares.
1 January 2026
··
INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

Intelligent Bio Solutions shares jumped 132% to $9.53 before dropping 14% after-hours as the company announced a $10 million private placement and a new manufacturing deal with Syrma Johari MedTech. The placement, priced at $4.35 per share and warrants, is set well below the closing price. Volume hit 108 million shares. The company recently enacted a 1-for-10 reverse split after a Nasdaq minimum bid warning.
1 January 2026
··
Nike stock jumps on CEO’s $1 million buy — what NKE investors watch next

Nike stock jumps on CEO’s $1 million buy — what NKE investors watch next

Nike shares rose 4.1% to $63.71 in the final 2025 session after CEO Elliott Hill bought 16,388 shares for about $1 million, according to an SEC filing. The gain came as Wall Street closed the year lower and Under Armour shares fell 3%. Trading volumes were thin ahead of the New Year’s Day market holiday. Investors are watching for updates on Nike’s margins and China demand as earnings approach.
1 January 2026
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 01.01.2026

E to E Transportation Infrastructure listed on NSE SME at ₹330.60, nearly 90% above its ₹174 IPO price after seeing 526.56 times oversubscription. British American Tobacco Malaysia’s parent holds 50% of shares, with individuals at 32%. Uni-Asia Group posted a 96% five-year TSR despite a 14% annual revenue decline. Nifty50 opened at 26,172.90 and Sensex gained about 100 points.
1 January 2026
··
1 … 891 892 893 894 895 … 1,894

Stock Market Today

  • GSK Share Price Dips Amid Pipeline Developments; Valuation Viewed as Undervalued at £19.01
    May 3, 2026, 5:56 PM EDT. GSK (LSE:GSK) shares slipped 1.4% on the day and 5.9% over the past week, pulling back 11.3% in a month after earlier gains this year. Despite this, the healthcare giant shows a 36.6% total return over one year, suggesting cooling momentum after strong gains. Analysts place GSK's fair value at around £78, far above the current share price near £19, implying significant undervaluation. This valuation hinges on successful late-stage drug approvals and upcoming regulatory decisions, including an FDA ruling expected soon. Key executives will present insights at major healthcare conferences this week, underscoring critical upcoming catalysts. Investors should weigh the optimistic outlook against risks tied to trial outcomes and regulatory reviews before reassessing their position in GSK stock.

Latest article

X-Energy’s $1 Billion Nuclear IPO Faces Its First Test After Wall Street Pop

X-Energy’s $1 Billion Nuclear IPO Faces Its First Test After Wall Street Pop

3 May 2026
X-Energy shares closed Friday at $30.53, up 33% from the $23 IPO price but down from last week’s high. Kentucky utilities LG&E and KU are studying deployment of X-Energy’s Xe-100 small modular reactor after the state approved new nuclear site-readiness grants. The company has yet to deliver a commercial reactor, with licensing, fuel, and construction still pending.
Bitmine’s $23 Million Ethereum Deal Puts BMNR Stock Back in the Spotlight

Bitmine’s $23 Million Ethereum Deal Puts BMNR Stock Back in the Spotlight

3 May 2026
The Ethereum Foundation sold 10,000 ETH to Bitmine Immersion Technologies for about $22.9 million in a private deal, bringing Bitmine’s holdings to over 5 million ETH, or 4.2% of the total supply. The transaction was completed at an average price of $2,292.15 per ETH. BMNR last closed at $21.88 on Friday. Ether traded near $2,327.
Go toTop